title: Use of impaza in the treatment of erectile dysfunction in patients with essential hypertension and CHD.
abstract: Impaza treatment of erectile dysfunction in patients with essential hypertension and CHD receiving cardiotropic therapy improved erectile function and increased reserve circulation. Addition of impaza to the treatment protocol in cardiological patients considerably increased perfusion and reduced the content of desquamated epitheliocytes. No side effects of impaza were noted.
authors.affiliation: Department of Urology and Nephrology, Altai State Medical University, Barnaul.
authors.forename: A I
authors.initials: AI
authors.lastname: Neimark
authors.forename: R T
authors.initials: RT
authors.lastname: Aliev
authors.forename: N I
authors.initials: NI
authors.lastname: Muzalevskaya
authors.forename: S V
authors.initials: SV
authors.lastname: Krainichenko
authors.forename: E N
authors.initials: EN
authors.lastname: Vorob'eva
authors.forename: T S
authors.initials: TS
authors.lastname: Tarasova
mesh_terms: D000368:Aged; D000906:Antibodies / Q000009:adverse effects / Q000627:therapeutic use*; D003327:Coronary Disease / Q000150:complications* / Q000378:metabolism; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D019001:Nitric Oxide Synthase / Q000378:metabolism
chemical_list: D000906:Antibodies; C534505:IMPAZA; D019001:Nitric Oxide Synthase